Report Detail
Global Diabetes Drug Therapy Market Insights, Forecast to 2025
- RnM2708159 |
- 06 May, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes. Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.
The global Diabetes Drug Therapy market is valued at 10000 million US$ in 2018 and will reach 21400 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Diabetes Drug Therapy market based on company, product type, end user and key regions.
This report studies the global market size of Diabetes Drug Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Diabetes Drug Therapy in these regions.
This research report categorizes the global Diabetes Drug Therapy market by top players/brands, region, type and end user. This report also studies the global Diabetes Drug Therapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott Laboratories
Mannkind Corporation
Bristol Myers Squibb
Medtronic
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
Sanofi
Novo Nordisk
Novartis International AG
Market size by Product
Glucagon-like peptide-1 (GLP-1) agonist
Dipeptidyl-peptidase-4 (DPP-4) inhibitors
Sodium glucose co-transporter 2 (SGLT2) inhibitors
Insulin
Others
Market size by End User
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Impaired Glucose Tolerance and Impaired Fasting Glycaemia
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Diabetes Drug Therapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Diabetes Drug Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Diabetes Drug Therapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Diabetes Drug Therapy submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Diabetes Drug Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Diabetes Drug Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Diabetes Drug Therapy Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Diabetes Drug Therapy Market Size Growth Rate by Product
- 1.4.2 Glucagon-like peptide-1 (GLP-1) agonist
- 1.4.3 Dipeptidyl-peptidase-4 (DPP-4) inhibitors
- 1.4.4 Sodium glucose co-transporter 2 (SGLT2) inhibitors
- 1.4.5 Insulin
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Diabetes Drug Therapy Market Size Growth Rate by End User
- 1.5.2 Type 1 Diabetes
- 1.5.3 Type 2 Diabetes
- 1.5.4 Gestational Diabetes
- 1.5.5 Impaired Glucose Tolerance and Impaired Fasting Glycaemia
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Diabetes Drug Therapy Market Size
- 2.1.1 Global Diabetes Drug Therapy Revenue 2014-2025
- 2.1.2 Global Diabetes Drug Therapy Sales 2014-2025
- 2.2 Diabetes Drug Therapy Growth Rate by Regions
- 2.2.1 Global Diabetes Drug Therapy Sales by Regions
- 2.2.2 Global Diabetes Drug Therapy Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Diabetes Drug Therapy Sales by Manufacturers
- 3.1.1 Diabetes Drug Therapy Sales by Manufacturers
- 3.1.2 Diabetes Drug Therapy Sales Market Share by Manufacturers
- 3.1.3 Global Diabetes Drug Therapy Market Concentration Ratio (CR5 and HHI)
- 3.2 Diabetes Drug Therapy Revenue by Manufacturers
- 3.2.1 Diabetes Drug Therapy Revenue by Manufacturers (2014-2019)
- 3.2.2 Diabetes Drug Therapy Revenue Share by Manufacturers (2014-2019)
- 3.3 Diabetes Drug Therapy Price by Manufacturers
- 3.4 Diabetes Drug Therapy Manufacturing Base Distribution, Product Types
- 3.4.1 Diabetes Drug Therapy Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Diabetes Drug Therapy Product Type
- 3.4.3 Date of International Manufacturers Enter into Diabetes Drug Therapy Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Diabetes Drug Therapy Sales by Product
- 4.2 Global Diabetes Drug Therapy Revenue by Product
- 4.3 Diabetes Drug Therapy Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Diabetes Drug Therapy Breakdown Data by End User
6 North America
- 6.1 North America Diabetes Drug Therapy by Countries
- 6.1.1 North America Diabetes Drug Therapy Sales by Countries
- 6.1.2 North America Diabetes Drug Therapy Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Diabetes Drug Therapy by Product
- 6.3 North America Diabetes Drug Therapy by End User
7 Europe
- 7.1 Europe Diabetes Drug Therapy by Countries
- 7.1.1 Europe Diabetes Drug Therapy Sales by Countries
- 7.1.2 Europe Diabetes Drug Therapy Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Diabetes Drug Therapy by Product
- 7.3 Europe Diabetes Drug Therapy by End User
8 Asia Pacific
- 8.1 Asia Pacific Diabetes Drug Therapy by Countries
- 8.1.1 Asia Pacific Diabetes Drug Therapy Sales by Countries
- 8.1.2 Asia Pacific Diabetes Drug Therapy Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Diabetes Drug Therapy by Product
- 8.3 Asia Pacific Diabetes Drug Therapy by End User
9 Central & South America
- 9.1 Central & South America Diabetes Drug Therapy by Countries
- 9.1.1 Central & South America Diabetes Drug Therapy Sales by Countries
- 9.1.2 Central & South America Diabetes Drug Therapy Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Diabetes Drug Therapy by Product
- 9.3 Central & South America Diabetes Drug Therapy by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Diabetes Drug Therapy by Countries
- 10.1.1 Middle East and Africa Diabetes Drug Therapy Sales by Countries
- 10.1.2 Middle East and Africa Diabetes Drug Therapy Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Diabetes Drug Therapy by Product
- 10.3 Middle East and Africa Diabetes Drug Therapy by End User
11 Company Profiles
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Abbott Laboratories Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Abbott Laboratories Diabetes Drug Therapy Products Offered
- 11.1.5 Abbott Laboratories Recent Development
- 11.2 Mannkind Corporation
- 11.2.1 Mannkind Corporation Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Mannkind Corporation Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Mannkind Corporation Diabetes Drug Therapy Products Offered
- 11.2.5 Mannkind Corporation Recent Development
- 11.3 Bristol Myers Squibb
- 11.3.1 Bristol Myers Squibb Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Bristol Myers Squibb Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Bristol Myers Squibb Diabetes Drug Therapy Products Offered
- 11.3.5 Bristol Myers Squibb Recent Development
- 11.4 Medtronic
- 11.4.1 Medtronic Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Medtronic Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Medtronic Diabetes Drug Therapy Products Offered
- 11.4.5 Medtronic Recent Development
- 11.5 AstraZeneca
- 11.5.1 AstraZeneca Company Details
- 11.5.2 Company Business Overview
- 11.5.3 AstraZeneca Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 AstraZeneca Diabetes Drug Therapy Products Offered
- 11.5.5 AstraZeneca Recent Development
- 11.6 Eli Lilly and Company
- 11.6.1 Eli Lilly and Company Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Eli Lilly and Company Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Eli Lilly and Company Diabetes Drug Therapy Products Offered
- 11.6.5 Eli Lilly and Company Recent Development
- 11.7 GlaxoSmithKline
- 11.7.1 GlaxoSmithKline Company Details
- 11.7.2 Company Business Overview
- 11.7.3 GlaxoSmithKline Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 GlaxoSmithKline Diabetes Drug Therapy Products Offered
- 11.7.5 GlaxoSmithKline Recent Development
- 11.8 Sanofi
- 11.8.1 Sanofi Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Sanofi Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Sanofi Diabetes Drug Therapy Products Offered
- 11.8.5 Sanofi Recent Development
- 11.9 Novo Nordisk
- 11.9.1 Novo Nordisk Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Novo Nordisk Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Novo Nordisk Diabetes Drug Therapy Products Offered
- 11.9.5 Novo Nordisk Recent Development
- 11.10 Novartis International AG
- 11.10.1 Novartis International AG Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Novartis International AG Diabetes Drug Therapy Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Novartis International AG Diabetes Drug Therapy Products Offered
- 11.10.5 Novartis International AG Recent Development
12 Future Forecast
- 12.1 Diabetes Drug Therapy Market Forecast by Regions
- 12.1.1 Global Diabetes Drug Therapy Sales Forecast by Regions 2019-2025
- 12.1.2 Global Diabetes Drug Therapy Revenue Forecast by Regions 2019-2025
- 12.2 Diabetes Drug Therapy Market Forecast by Product
- 12.2.1 Global Diabetes Drug Therapy Sales Forecast by Product 2019-2025
- 12.2.2 Global Diabetes Drug Therapy Revenue Forecast by Product 2019-2025
- 12.3 Diabetes Drug Therapy Market Forecast by End User
- 12.4 North America Diabetes Drug Therapy Forecast
- 12.5 Europe Diabetes Drug Therapy Forecast
- 12.6 Asia Pacific Diabetes Drug Therapy Forecast
- 12.7 Central & South America Diabetes Drug Therapy Forecast
- 12.8 Middle East and Africa Diabetes Drug Therapy Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Diabetes Drug Therapy Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Diabetes Drug Therapy . Industry analysis & Market Report on Diabetes Drug Therapy is a syndicated market report, published as Global Diabetes Drug Therapy Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Diabetes Drug Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
